2021
DOI: 10.3390/ijns7040070
|View full text |Cite
|
Sign up to set email alerts
|

Towards a Newborn Screening Common Data Model: The Utah Newborn Screening Data Model

Abstract: As newborn screening programs transition from paper-based data exchange toward automated, electronic methods, significant data exchange challenges must be overcome. This article outlines a data model that maps newborn screening data elements associated with patient demographic information, birthing facilities, laboratories, result reporting, and follow-up care to the LOINC, SNOMED CT, ICD-10-CM, and HL7 healthcare standards. The described framework lays the foundation for the implementation of standardized ele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…A review of the importance of timing in diagnosing and treating presymptomatic SMA patients identified through NBS was reported in 2021 with a recommendation for treatment by 14 days of life) [ 337 ]. Also in 2021, a data model was described that provides a foundation for implementing a standardized electronic data exchange across NBS programs that can accelerate implementation of electronic data exchange between healthcare providers and NBS programs ultimately improving health outcomes [ 338 ]. Two other reports in 2021 dealt with secondary screening testing: a report describing a scalable, exome sequencing-based next-generation sequencing (NGS) pipeline with a priori analysis restriction that can be universally applied to any NBS disorder [ 339 ]; and a report discussing how NGS can be used as a NBS secondary testing method, the importance of genomic variant repositories for the annotation and interpretation of variants and barriers to incorporation of NGS and bioinformatics into NBS systems [ 340 ].…”
Section: Resultsmentioning
confidence: 99%
“…A review of the importance of timing in diagnosing and treating presymptomatic SMA patients identified through NBS was reported in 2021 with a recommendation for treatment by 14 days of life) [ 337 ]. Also in 2021, a data model was described that provides a foundation for implementing a standardized electronic data exchange across NBS programs that can accelerate implementation of electronic data exchange between healthcare providers and NBS programs ultimately improving health outcomes [ 338 ]. Two other reports in 2021 dealt with secondary screening testing: a report describing a scalable, exome sequencing-based next-generation sequencing (NGS) pipeline with a priori analysis restriction that can be universally applied to any NBS disorder [ 339 ]; and a report discussing how NGS can be used as a NBS secondary testing method, the importance of genomic variant repositories for the annotation and interpretation of variants and barriers to incorporation of NGS and bioinformatics into NBS systems [ 340 ].…”
Section: Resultsmentioning
confidence: 99%
“…In a similar approach, the development of a data model that includes mapping to SNOMED CT, LOINC, ICD-10, has been described for the Utah Newborn Screening (NBS) Program to improve the data exchange between healthcare providers and NBS programs. This leads to a reduced dependency on proprietary laboratory information systems 38 .…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, two contributions from the Utah NBS program are also worth mentioning. One of these, by Jones et al [ 4 ], addresses a potential framework for the development of a shared data model for standardized electronic data exchange across NBS programs, and the other, by Ruiz-Schultz et al [ 5 ], presents a potential blueprint for a shared bioinformatics platform as more next-generation sequencing (NGS) is adopted for second-tier testing in NBS.…”
mentioning
confidence: 99%